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TABLE II. Concentration of histamine in hum an shin exudate:; 
following 2.5 MEDs ol UVA irradiation 
J h 
5.0 ± 2. 1 
n=4 
Concenlralion of histamine (ng. ml 1) 
(mean ± SEM) 
5 h 9 h 15 h ~4 h 
4.6 ± l. 7 7.4 ± 2.8 13.6 ± 8.6 2.0 ± 0.4 
n= 7 n =8 n= 8 n = 15 
Average baseline value= 3.3 ng.ml 1 (range 0-6 ng.ml 
48 h 
0.7 ± 0.7 
n =3 
'). 
panimen t of irradiation of skin over t he whole UV wavelength 
spectrum and we suggest that t his activity plays an important 
role in t h e onset a nd development of t h e eaTlie r stages of the 
inflammatory response. This response sh ould theTefore be re-
duced by adm inistration of cyclooxygenase inhibi tors, e .g., in-
domethacin, a nd although one previous study (14] has not 
confiTmed this, further such wo rk needs to be undertaken. The 
mediators of t he later stages of the inflammatory response 
remain unknown and further work is required to elucidate th eir 
nature. 
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The local pharmacodynamics of a topical vasodilator 
(methyl nicotinate ) has been followed noninvasively u s -
ing photopulse plethysmography. This t echnique is sen-
sitive to changes in blood flow through the cutaneous 
microcirculation and r esponds to the pharmacologic 
stimulus of the vasoactive agent employed. Five differe nt 
application sites for the drug w ere studied and the time 
course of the local effect (i.e., onset, duration, and decay) 
was recorded. The applied amount of drug e licite d, 
within a short period, a response which was saturable 
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Abbreviations: 
PPG: photoplethysmography 
PW A: pulse wave ampli tude 
s uch that the observed increase in blood flow reached a 
plateau level. The decay of the e levated perfusion re-
quired approximately 1 h, suggesting a h a lf-life for elim-
ination of the drug from the skin of about 10 min. T hi s 
r esult agrees closely with othe r reported values and 
suggests that the pharmacodynamic m easm·e m ents of 
this study may prove useful in e lucidating aspects of 
dermal pharmacokinetics. 
Information a bout t he t ime course of drug behavior at and 
within th e region of topical application is of considerable im-
portance to t he rational design of dermatologic th erapy for use 
in the clinical sit uation . A convenient way to investigate in vivo 
th e cutaneous action of vasodilatory or vasoconstrictive drugs 
is through t heir effects on th e cu taneous microcirculation . 
Among the currently ava ila ble techniques (1], which include 
direct visualiza tion, plethysmography in its various forms, t h er -
mal measurem ents, dye techniques, radio isotope clearance 
m ethods, a nd laser Doppler spectroscopy [2], photoplethys-
mography (PPG) (3] offers certain distinct advan tages over 
many of t he alterna tive m ethods. In PPG, a small probe t hat 
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contains a light source and a photodetecto r is attached to the 
skin surface. Light from the source enters the skin and is t hen 
multiply scattered by the skin blood back into the detector. 
T he wavelength of incident rad iation used in PPG lies in the 
range of 800-900 nm where the transmission t hrough the skin 
is large compal'ed with blood. PPG is commercially availa ble at 
prices much lower than laser Doppler velocimeters. Although 
the results cannot be reliably quantified in the absolute sense 
(it is even not clear whether more reflected light indicates more 
or less blood [ 4]), this same objection holds for most other 
methods as well [1,5]. PPG has a long history [3] a nd most 
recently has been applied successfully to screen patients wi th 
significant obstruction of the extracranial carotid artery 
[6,7,:j:], to assess and differentiate between superficial and deep 
insufficiency in the lower leg [8], and to evaluate the healing 
potential of skin ulcers [9]. In the pharmacologic context, both 
vasodilatory and vasoconstrictive topically applied agents have 
been studied using PPG [3]. Cummings [10] investigated the 
temperature and concentration effects on the initial stages of 
the penetration of N -octylamine through the human skin, while 
Thune [11] measured the full t ime course of vasoconstrictive 
steroids in normal and stripped skin and found it to be on the 
order of several days. 
Here, we have employed PPG to monitor both the onset and 
decay of t he effect of methyl nicotinate (3-pyridine cru·boxylic 
acid, methyl ester) absorbed through t he skin . Nicotinic acid 
a nd its esters are potent topical vasodilators, rapidly elicit ing a 
distinctive erythema after application [12]. Indeed, the onset of 
erythema often has been used as a convenient physiologic end 
point with which to quantify the skin absorption of these 
compounds [13]. Subsequent to the appearance of redness, the 
erythematous ru·ea (i) spreads radially to a maximum (and 
increases in intensity) before (ii) gradually fading away. The 
former process has recently been visually measured and inter-
preted [14]. The latter, however, involves too much subjectivity 
to be so treated. It seems reasonable to expect that the rate of 
disappearance of erythema will be closely related to the removal 
of drug by the dermal capillaries into the systemic ci..rculation . 
In terms of the nicotinate life-time within the skin, therefore, 
this event is particularly pertinent. Because PPG is able to 
refl ect altera tions in skin blood flow , as shown by the works of 
He1tzman and associates [15-20] , it seemed likely that the 
technique would prove capable of providing an indication of 
both the arrival and removal of methyl nicotinate into and from 
t he skin . 
We report noninvasive experiments using PPG which a llow 
us to assess the local pharmacologic effect of methyl nicotinate 
fo llowing topica l application. Data are presented for the time 
course of drug penetration at various sites on the body from 
the time of application up to the return of the photoplethys-
mog:raphic response to its baseline level. 
MATERIALS AND METHODS 
Methyl nicotinate (1 M aqueous solu tion) was topically applied to 
the upper and lower forearms, upper and lower back, and shins of' 3 
volun teers. Each experiment included simultaneous recording of 2 sites, 
usually bilateral and symmetrica l. Every chosen site was first recorded 
with the photoplethysmograph (see below) to indicate t he baseline and 
thus to eliminate sites above ectasia or veins, which give rise to high 
readings and lower sensitivities. Each site was exposed to the methyl 
nicotinate for 15 s through a sa turated Imeco Ab (Sweden) (AI T est) 10 
mm-diameter test patch 'and then cleansed with a t issue paper. The 
skin was not pretreated or cleansed. 
A MedaSonics PPG 13 photoplethysmograph was used with a PH77 
reflectance sensor. This small rectangula r sensor (2.1 X 1.0 X 0.7 em) 
houses a ligh t-emitting diode and a phototransistor wh ich detects that 
portion of the transmitted light that was refl ected from blood in sma ll 
:j:Barnes RW: Photoplethysmography in periphera l vascular disease. 
Presented at the III International Cardiovascula r Congress, February 
16-18, 1981, Scottsdale, Arizona. 
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superficial vessels. §The electrical output of' the phototrans istor is, 
therefore, amplitude modulated according to the changing volu me of 
blood in the microcirculati<?n. To ensure repeatabili ty , we used t he 
PPG 13 in its arterial mode in which s low changes in venous or regional 
blood fl ow a re not detected and only the rapid ly changing pu lsatile 
s ignals produced by arteria l blood volume changes in the microcircu-
lation a re amplified (with a 0.5-16 Hertz freque ncy response) . The 
simul taneous outputs of2 sensors were recorded on a Rl2A M edaSonics 
chart recorder. After equa lizing the sensors ' outputs with the a id of a 
MedaSonics ca librator, 11the sensors were placed on the chosen sites 
using a transparent double-sided tape. 
The whole procedure fo r drug application and probe posit ioning at 
the 2 sites took less t han 1 min. A con tinuous recording was taken for 
the first 10 min, fo llowed by 30- · recordings every 5 min. 
We a lso recorded the PPG response following in tradermal inj ection 
of (i) 50 1.d of 1 X l 0- ·1 M methyl nicotinate solu tion in normal saline, 
(ii) 50 iJ.l of 1 X 10-" M methyl nicotinate solu t ion in normal sa line, and 
(iii ) 50 iJ.l of normal saline in to the fl exor aspect of' t he forearms of 
subject l. 
All experiments were performed in a single we ll -ventilated room at 
a temperature of 22 ± 2°C and at a relative humidi ty in t he range of 
50-70%. 
RESULTS 
Typical recorder outputs from the upper forearm apperu· in 
Fig L It is readily seen that while the amplitude of the volume 
pulsations of the microciTculation blood does not change appre-
ciably immediately after the application of the methyl nicotin-
ate (Fig la.,b) , a substant ia l amplitude increase follows (Fig l c) 
with a subsequent decay (Fig lei) to the baseline level. 
Fig 2 depicts the time dependence of the peak- to-peak am-
plitude of the pulsations as determined from samples of the 
recorder output for the upper forearms of l of the subj ects, 
(-- left forearm,---- right forearm) . The figure shows the 
pulse wave amplitude, PWA, as weU as the ratio 
PWA . h . I li p on a logant m1c sea e. base ne WA 
Similar measurements of the remaining 2 volunteers pro-
duced qualitatively the same results. The pa t tern of response 
seen at the other 4 sites tested (lower forearm, upper and lower 
back, and shins) was consistent with that shown in Fig 2. A 
PWAjEY B 
PWAj~ g 
----1~ 
1second 
FIG l. A typical t ime sequence of t he photoplethysmograph output 
following topical application of methyl nicotinate. Base line (a); a fter 
1.5 min (b) ; a fter 15 min (c); after 65min (d) . 
§The incident light of the source is reported to penetrate to a depth 
of 1-1.5 mm (MedaSonics, technica l information). 
111ngle FW: Calibrat ion of the photoplethysmograph PPG. Presented 
at the 34th Annual Conference on Engineering in Medicine and Biology, 
September 21-23, 1981, Houston, T exas. 
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Frc 2. Time dependence of the peak-to-peak amplitude, PWA, up-
per forearm. a, Direct reading from recorder output. b, The natural 
logarithm of the ratio B ~W APW . Solid line: left upper forearm. 
ase me A 
Dotted line: right upper forearm. 
TABLE I. Swnmary of photoplethysrnographic data" from 3 
volunteers following topical application of methy l nicotinate 
(quadruplicate readings were tahen for I of the subjects, duplicate 
readings for the other 2) 
Site 
Upper forearm 
Lower forearm 
Upper back 
Lower back 
Shins 
Time to max PW A Time to decay ( max PW A ) 
(min ) (min) In Baseline PWA 
7.5 ± 2.2 
5.7 ± 0.8 
6.4 ± 2.5 
7.0 ± 0.5 
9.2 ± 3.3 
75.2 ± 7. 1 
70.0 ± 8.8 
67.5 ± 11.9 
80.0 ± 5.1 
80.0 ± 6.1 
1.99 ± 0.3 
1.76 ± 0.3 
1.85 ± 0.2 
1.64 ± 0.4 
1.47 ± 0.2 
" Tabu lated values of the average resul ts for the 3 su bjects± SD. By 
Anova the data from the 5 sites are not statistically different. 
summary of the observations is given in Table I. The results 
from the in tradermal injection experiments are shown in Fig 3. 
DISCUSSION 
It is important first to point out that the rapid rise in PPG 
output correla tes closely with the visual observation of ery-
thema onset. In a preliminary account (21], we have presented 
dose-response data for methyl nicotinate using both PPG and 
laser Doppler velocimetry techniques. 
In the work reported here, the same pattern of PPG response 
is seen at all sites and beru·s a reasonable resemblance to that 
reported by H ertzman and Randall in 1948 after methacholine 
iontophoresis [19]. D espite some variation among our subjects 
and from site to site, the relative change from baseline PPG 
response is basically the same at each position, suggesting that 
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FIG 3. Time dependence of the peak-to-peak amplitude, PWA , fol-
lowing injection of saline to the left lower foreann (solid lin e ) and 50 
11! of methyl nicotinate to the right lower fo rearm (dolled line, 1 x 10 2 
M; dotted-dashed line, 1 X w-·> M). a, Direct reading from recorder 
II . h f I . PWA 
output. b, The natura ogan t m o L 1e ratw baseline PW A . 
the applied amount of nicotinate perturbs the local microvas-
culature in an approximately equal fashion. The differences 
that we find among "resting" (no drug) PPG responses, i.e., 
blood flow, at the various positions al'e in general agreement 
with oldel' data [15,19]. Currently in our laboratory, further 
work is being undertaken to more clearly reveal the regional 
va1·ia tion of blood flow in the dermal ci.J"culation. 
Each of the response Clll'Ves, having risen rapidly, reaches a 
plateau region. This observation resembles that reported by 
Cummings [10] for the penetration of N-octylamine, alt hough 
it should be pointed out that the latter compound has a different 
mechanism of action from that of methyl nicotinate. The char-
acter of the response seen in our studies suggests that the 
quantity of vasodilator absorbed in a 15-s application is suffi-
cient to produce a saturating effect. This is tru e at each position 
studied and is not influenced by the magni tude of the baseline 
PPG response detected. 
It is a reasonable postulate that the observed effect caused 
by methyl nicotinate is related to t he amount of the compound 
present at the site where it elicits its action. We may speculate 
that the relationship between effect and amoun t is a function 
of the number of blood vessels accessible to the drug, i. e., the 
number of active sites or receptors, and the degree to which 
each vessel has been, or has the potential to be, dilated. 
It follows that, in a qualitative sense, we ru·e able in the above 
fashion to provide a simple, acceptable explanation of the 
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experimental observations. A more quantitative approach is 
made more difficult with these data because of the saturation 
phenomenon described. However, by assuming a facile kinetic 
simulation describing the arrival of drug at its site of action, 
and its removal therefrom, it is possible to quantify the elimi-
nation process from the local region of skin as follows: 
Schematically the model is shown in Fig 4. The concentration 
(c) of drug in the single compartment, assuming first order 
kinetics for the input and elimination processes, is given by: 
(1) 
where h; and h,. are defined in Fig 4 and K is a constant. We 
recognize that the simple equation cannot account for the 
plateau regions in th e graphs of our results. Eq (1), therefore, 
will be applicable to an ideal experiment in which the maximum 
concentration of drug obtained at the active site is below the 
saturation level. Subseq uent experiments in our laboratory 
(unpublished results), using lower nicot inic acid ester concen-
trations, are confirming this hypothesis, and on the basis of this 
information, we suggest that Eq (1) represents a suitable start-
ing point for the analysis of the data. The late time decay of a 
curve described by Eq (1) is characterized by the slower of the 
two constants, h; or he [22]. Because the observations reported 
here unanimously support a rapid initial response increase, it 
seems likely that, for methyl nicotinate, h; > h e. Hence, we can 
use the ma nner in which the PPG response decays to estimate 
he. In the majority of the experiments, the maximum response 
is reached between 10-20 min, and the decay to baseline r e-
quires 60-80 min. Crudely, we may equate the difference be-
tween these two values to 6 elimination half-lives, i.e. , 
t1/2[ elimination ] :::: 10 min 
which corresponds to 
It is in teresting to note that this value agrees closely with that 
determined in a study which considered the radial spread of 
erythema !3aused by the same nicotinic acid ester [23]. A h, 
value of similar magnitude may also be deduced from an 
investigation [24] that monitored in situ the disappearance of 
intradermally injected radioactive phosphate, and the early 
experiment using photoplethysmography by Hertzman and 
Randall [19], which recorded blood flow change after metha -
ch oline iontophoresis. It is appropriate to reiterate at this point 
that the procedme employed to extract he is simplistic. More 
sophisticated reductions are possible, but their use is not yet 
justified given the precision and qu antity of da ta so far obtained. 
_ ...... 
input 
Site[s] oF 
drug action 
k-e elimination 
FIG 4. Schematic representation of the model employed to obtain 
the elimination half-life of methyl nicotinate fTom the region of skin to 
which application is made. 
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The intradermal injections were undertaken in this study to 
provide a sensible "control " system and, subsequently, to in-
quire further into the apparent generality of t he rate of the he 
process. Several features of the data in Fig 3 are of interest. 
Firstly, we see a cutaneous blood flow response to injection 
trauma because there is a significant change in PPG output 
following administration of saline. This effect h as been reported 
upon recently by Holloway [5] using laser Doppler velocimetry. 
Secondly, the response decay after intradermal delivery of 
nicotinate parallels closely that found following a topical appli-
cation. It is clear, therefore, that methyl nicotinate is a ble to 
relatively rapidly cross human stratum corneum. Thirdly, the 
2 intradermal injections of drug (50 }J.l of 1 X 10- 2 M and 50 11-l 
of 1 X 10- 4 M) correspond to the introduction of 68.5 J.l.g and 
0.685 J.l.g of methyl nicotinate, respectively. Obviously, there is 
not a 100-fold difference in the microcirculation response as 
recorded by PPG. It follows that, at present, it is very difficul t 
to correlate the magnitude of the PPG response with a discrete 
amount of drug at the active site(s). The problem may well be 
related to the "saturation" phenomenon discussed earlier. T o 
probe the relationship between response and amount of drug 
clearly requires further investigation in which applied drug 
concentration and skin contact time and area are important 
variables. The availability of other nicotinic acid esters of 
different physicochemical characteristics (e.g., size, solubility, 
lipid/ water affinity), yet consistent pharmacologic efi"ects [12], 
offers another route to study the potent ia l connection among 
our pharmacodynamic measm ements, drug availability at af-
fector locations, and eventually, it is hoped, the percuta neous 
a bsorption process itself. 
In conclusion, it appears that the PPG technique can monitor 
the time course of vasoactive drug behavior in the local region 
of skin to which the compound is applied. A simple treatment 
of the results has allowed a n aspect of cutaneous pharmacoki-
netics to be addressed and the half-life for drug elin1ination to 
be estimated. We emphasize that the latter calculation implies 
a direct relationship between drug · effect and drug presence, 
absolute confu·mation of which is an objective pw·sued in our 
ongoing r esearch. 
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Characterization of a- and P-Adrenergic Agonist Stimulation of 
Adenylate Cyclase Activity in Human Epidermal Keratinocytes In Vitro* 
ELAINE K. 0RENBERG, PH.D., EvA A. PFENDT, B.A., AND DAviD I. WILKINSON, PH.D. 
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Adrenergic receptors are responsible for selective rec-
ognition and binding of catecholamines and may in turn 
have an effect on epidermal cell growth and maturation 
via adenosine-3',5'-monophosphate (cAMP). Using en-
dogenous catecholamines and drugs specific for a- and 
,8-receptor subtypes, we have characterized the adrener-
gic receptor coupled to adenylate cyclase in cultured 
human epidermal keratinocytes. The relative potency 
order of stimulation of adenylate cyclase was: isoproter-
enol > epinephrine » norepinephrine. The predominant 
adrenergic receptor is of the ,82-subtype, as also con-
firmed by use of the selective antagonists propranolol, 
butoxamine, and atenolol. No evidence of a-adrenergic 
receptor mediation of adenylate cyclase was noted with 
the a2-specific agonist, clonidine. Phenylephrine, the a1-
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Abbreviations: 
cAMP: adenosine-3 ',5'-monophosphate 
E PI: epinephrine 
IBMX: isobutylmethylxanthine 
ISP: isoproterenol 
NE: norepinephrine 
PBS: phosphate-buffered saline 
PRP: propranolol 
RIA: radioimmunoassay 
specific agonist, affected cAMP formation but this r e -
sponse could not be totally inhibited with prazosin, sug-
gesting an unknown mechanism of action. Human k e r-
atinocytes retained the same ,8-adrenergic receptor po-
tency order properties throughout growth and matura-
tion. 
In many mammaljan systems cyclic AMP affects cellular 
metabolism by processes leading to growth enha ncemen t or 
restriction . Epidermal keratinocytes possess a series of cell 
surface receptors for catechola mines [1], histamine [2), adeno-
sine [3,4), and prostaglandins E 1 and E2 [5] which are coupled 
to adenylate cyclase. While species differences do occu1· in the 
magnitude of response a nd order of sensitivity to a variety of 
agonjsts, we previously have shown that the adenylate cyclase 
of human keratinocytes is most sensitive to agents that stimu-
late the catecholamine receptor [6]. That this receptor m ay be 
important with regard to regulation of epidermal growth is 
suggested by the fa ct that several laboratories have indepen-
dently reported that involved psoriat ic epidermis in vitro has a 
decreased response to catecholamines [7- 9], which has been 
confirmed by cytochemical a nalysis [10]. Also, in tissue s lices 
of epidermis t hat had been treated with hexadecane to produce 
hyperplasia, t he increased proliferation, amino acid incorpora-
t ion, and glycolysis were associated with loss of responsiveness 
to ,8-adrenergic agonists [ 11]. 
Adrenergic receptors a re responsible for selective recognjtion 
and binding of catecholamines a nd may mediate qu ite distinct 
cell fun ctions. B eta-adrenergic receptors have been ident ified 
on membra ne preparations of numerous ma mmalia n cells in-
cluding rodent a nd human skin cells [12-14). In this commu-
nication we focus on characterization of the recep tor subtypes 
coupled to adenylate cyclase in human epidermal keratinocyte 
grown in vitro. Alpha- a nd ,8-adrenergic receptor subtype clas-
